Art

J-GLOBAL ID：201602268853026824   Reference number：16A1102019

Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

生体肝移植後の再発C型肝炎に対するシメプレビル/ペグインターフェロン/リバビリン3種併用療法

Author (20)： Shinoda Masahiro (Department of Surgery) ,  Ebinuma Hirotoshi (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. [e-mail]) ,  Itano Osamu (Department of Surgery) ,  Yamagishi Yoshiyuki (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Obara Hideaki (Department of Surgery) ,  Kitago Minoru (Department of Surgery) ,  Nakamoto Nobuhiro (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Hibi Taizo (Department of Surgery) ,  Yagi Hiroshi (Department of Surgery) ,  Abe Yuta (Department of Surgery) ,  Matsubara Kentaro (Department of Surgery) ,  Chu Po-sung (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Wakayama Yuko (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Taniki Nobuhito (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Yamaguchi Akihiro (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Amemiya Ryusuke (Department of Surgery) ,  Miyake Rei (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Mizota Takamasa (Department of Surgery) ,  Kanai Takanori (Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Kitagawa Yuko (Department of Surgery)
Material： Hepatology Research  (Hepatol Res)
Volume： 46  Issue： 11  Page： 1118-1128  Publication year： Oct. 2016 
JST Material Number： W1284A  ISSN： 1386-6346  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： calcineurin inhibitor ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1102019&from=J-GLOBAL&jstjournalNo=W1284A") }}

Author keywords (6)： calcineurin inhibitor ,  direct-acting antiviral agent ,  living donor liver transplantation ,  recurrent hepatitis C ,  simeprevir ,  virological response

JST classification (2)： Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G) ,  Treatment for infectious diseases,parasitic diseases.  (GD01030D)

Substance index (2)： Simeprevir ,  Ribavirin

Reference (32)：

• WHO. WHO Fact Sheet number 164. - Hepatitis C. In; 2012.
• Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673-84.
• Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122:889-96.
• Akamatsu N, Sugawara Y, Kokudo N, et al. Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int 2014; 27: 767-74.
• Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 1433-44.

Terms in the title (7)： 生体肝移植 ,  再発 ,  C型肝炎 ,  シメプレビル ,  ペグインターフェロン ,  リバビリン ,  併用療法